Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial
Jayant S. Vaidya(University College London), Jeffrey Tobias(University Hospitals Birmingham NHS Foundation Trust), Michael Douek(Nuffield Orthopaedic Centre), Frederik Wenz(University Medical Center Freiburg), Magali Le Blanc‐Onfroy, Marcus Niewald(Saarland University), Konstantin J. Dedes(University Hospital of Zurich), Michael Alvarado(University of California, San Francisco), Jens‐Uwe Blohmer(Sankt Gertrauden Krankenhaus), Max Bulsara(The University of Notre Dame Australia), Tammy Corica(Sir Charles Gairdner Hospital), Montserrat Pazos(LMU Klinikum), Mary Falzon, Ingrid Potyka(University College London), Wojciech Polkowski(Medical University of Lublin), David R. McCready(University Health Network), Steffi Pigorsch(Technical University of Munich), Steinar Lundgren(St Olav's University Hospital), Norman Williams(University College London), Christobel Saunders(Royal Women's Hospital), Pond R. Kelemen(New York Medical College), Samuele Massarut(Centro di Riferimento Oncologico), Richard Hoefer(Sentara Norfolk General Hospital), Günther Gruber(Breast Center), Dennis R. Holmes(University of Southern California), Fernando A. Bozza(D’Or Institute for Research and Education), Lorenzo Vinante(Centro di Riferimento Oncologico), Elena Sperk(Heidelberg University), Henrik Flyger(University of Copenhagen), Marc Sütterlin, David Joseph(The University of Western Australia), Michael Baum(International Center for Agricultural Research in the Dry Areas), Douglas Brown(Ninewells Hospital), Nicholas Roberts(University College London), Siobhan Laws(IQVIA (France)), Marcelle Bernstein, Chris Brew‐Graves(Royal Free London NHS Foundation Trust), Gloria Petralia(Royal London Hospital), W. Eiermann(Ludwig-Maximilians-Universität München)
Cited by 293
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
Gastric cancer: epidemiology, prevention, classification, and treatment
|Cancer Management and Research|2018|1.1k